PTC公司

最新新闻

• 评级变动
  Cantor Fitzgerald Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $130
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 公司公告
  PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klein Matthew B.
  SEC · 2026/4/24
• 公司公告
  GIIB: Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - PROWEALTH MANAGEMENT (PTC) LIMITED
  Bursa Malaysia · 2026/5/21
• 评级变动
  Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $109
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• 评级变动
  Cantor Fitzgerald Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $137
  \u5e02\u573a\u8d44\u8baf · 2026/9/22
• 评级变动
  Loop Capital Downgrades PTC Inc(PTC.US) to Hold Rating, Cuts Target Price to $205
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• A Quick Look at Today's Ratings for PTC Inc(PTC.US), With a Forecast Between $205 to $205
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 公司公告
  PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klein Matthew B.
  SEC · 2026/5/16
• 公司公告
  PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klein Matthew B.
  SEC · 2026/3/14
• This Week's Top U.S. Stocks | PTC has risen nearly 35% for the week, securing a $22.6 billion acquisition by Schneider Electric; in Brazil's presidential election, the pro-market camp outperformed expectations, boosting Bradesco Bank by more than 16%; Petroleo Brasileiro SA Petrobras gained over 14%, as Middle East tensions drove oil prices higher.
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 评级变动
  RBC Capital Maintains PTC Therapeutics(PTCT.US) With Hold Rating, Cuts Target Price to $75
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  KeyBanc Maintains PTC Inc(PTC.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/4
• 评级变动
  Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $122
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  BofA Securities Maintains PTC Therapeutics(PTCT.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• With a 42% premium and a five-year timeline to break even on the cost of capital, Schneider Electric's record $23 billion acquisition of PTC has triggered a sharp decline in its share price.
  wallstreetcn · 2026/10/6
• 评级变动
  TD Cowen Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $90
  \u5e02\u573a\u8d44\u8baf · 2026/8/31
• PTC SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES PTC INC.
  PR Newswire · 2026/10/6
• Correction to PTC Rating on Oct. 5
  Dow Jones · 2026/10/6
• 公司公告
  4: PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Smith Mary L.
  SEC · 2026/7/14
• 评级变动
  Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $122
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  Goldman Sachs Maintains PTC Therapeutics(PTCT.US) With Sell Rating, Raises Target Price to $70
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Raises Target Price to $109
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  BofA Securities Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $96
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  Wells Fargo Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $106
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  Barclays Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $120
  \u5e02\u573a\u8d44\u8baf · 2026/8/4

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。